Get started
Author

Iqra Furqan Ahmed

Observed name: I Ahmed
ORCID: 0009-0006-1123-1228
Observed ORCID: 0009-0006-1123-1228
OpenAlex ID: A5113531044
Elafibranor (Iqirvo) unveiled: a groundbreaking FDA-approved therapy revolutionizing primary biliary cholangitis treatment
2024 · Iqra Furqan Ahmed, Fatima Rizwan, et al. · Annals of Medicine and Surgery · 6
Unlocking the potential of glucagon-like peptide-1 receptor agonists in revolutionizing type 2 diabetes management: a comprehensive review
2024 · Nandan Joshi, Kanwal Mir Baloch, et al. · Annals of Medicine and Surgery · 5
Imetelstat (Rytelo): a promising treatment for adults with lower-risk MDS and transfusion-dependent anemia
2024 · Iqra Furqan Ahmed, Ayman Tahseen, et al. · Annals of Medicine and Surgery · 3
Hope on the horizon: FDA approves eplontersen for hereditary transthyretin-mediated amyloidosis
2024 · Insa Binte Anwar, Iqra Furqan Ahmed, et al. · Annals of Medicine and Surgery · 1
Impact of mixed versus monospecies malaria on organ dysfunction and hospital course: A retrospective cohort study from Karachi, Pakistan
2026 · Amaar H. Zaidi, Syeda Nosheen Zehra, et al. · Research Square
PDF
POSTER: CT-1095: Beyond CRS: Systematic Review of Immune Effector Cell–Associated Hemophagocytic Syndrome After CAR-T Therapy
2026 · Adeena Musheer, Tuba Basit, et al. · Clinical Lymphoma Myeloma & Leukemia
CT-1095: Beyond CRS: Systematic Review of Immune Effector Cell–Associated Hemophagocytic Syndrome After CAR-T Therapy
2026 · Adeena Musheer, Tuba Basit, et al. · Clinical Lymphoma Myeloma & Leukemia
PMO-043 Outcome of percutaneous endoscopic gastrostomy—how compliant we are with BSG guidelines?
2012 · I Ahmed, K Belfield, et al. · Gut
PDF
Works count: 8
Citation count: 15
H-index: 3
I10-index:
Year
Topic
Type